The activation of the adaptor protein STING depends on its interactions with the phospholipid PI4P

Rutger D Luteijn,Sypke R van Terwisga,Jill E Ver Eecke,Liberty Onia,Shivam A Zaver,Joshua J Woodward,Richard W Wubbolts,David H Raulet,Frank J M van Kuppeveld,Rutger D. Luteijn,Sypke R. van Terwisga,Jill E. Ver Eecke,Shivam A. Zaver,Joshua J. Woodward,Richard W. Wubbolts,David H. Raulet,Frank J. M. van Kuppeveld
DOI: https://doi.org/10.1126/scisignal.ade3643
IF: 9.517
2024-03-13
Science Signaling
Abstract:Activation of the endoplasmic reticulum (ER)–resident adaptor protein STING, a component of a cytosolic DNA–sensing pathway, induces the transcription of genes encoding type I interferons (IFNs) and other proinflammatory factors. Because STING is activated at the Golgi apparatus, control of the localization and activation of STING is important in stimulating antiviral and antitumor immune responses. Through a genome-wide CRISPR interference screen, we found that STING activation required the Golgi-resident protein ACBD3, which promotes the generation of phosphatidylinositol 4-phosphate (PI4P) at the trans-Golgi network, as well as other PI4P-associated proteins. Appropriate localization and activation of STING at the Golgi apparatus required ACBD3 and the PI4P-generating kinase PI4KB. In contrast, STING activation was enhanced when the lipid-shuttling protein OSBP, which removes PI4P from the Golgi apparatus, was inhibited by the US Food and Drug Administration–approved antifungal itraconazole. The increase in the abundance of STING-activating phospholipids at the trans-Golgi network resulted in the increased production of IFN-β and other cytokines in THP-1 cells. Furthermore, a mutant STING that could not bind to PI4P failed to traffic from the ER to the Golgi apparatus in response to a STING agonist, whereas forced relocalization of STING to PI4P-enriched areas elicited STING activation in the absence of stimulation with a STING agonist. Thus, PI4P is critical for STING activation, and manipulating PI4P abundance may therapeutically modulate STING-dependent immune responses.
cell biology,biochemistry & molecular biology
What problem does this paper attempt to address?
The problem that this paper attempts to solve is **to explore the regulatory mechanism of STING activation**, especially the role of phosphatidylinositol 4 - phosphate (PI4P) in the process of STING activation. Specifically, through genome - wide CRISPR interference screening, the researchers found that STING activation requires the Golgi - resident protein ACBD3, which promotes the production of PI4P at the trans - Golgi network. In addition, the study also explored the effects of other PI4P - related proteins on STING activation and the possibility of therapeutically modulating STING - dependent immune responses by regulating PI4P levels. ### Main findings 1. **The role of ACBD3 in STING activation**: - ACBD3 expression is necessary for the effective activation of STING. After knocking out ACBD3 by CRISPR interference (CRISPRi) and the CRISPR - Cas9 system, STING activation is significantly reduced. - The deletion of ACBD3 causes STING to be unable to relocate from the endoplasmic reticulum (ER) to the Golgi apparatus, and the phosphorylation and clustering of STING are also inhibited. 2. **The importance of PI4P in STING activation**: - STING is located in a PI4P - rich environment. ACBD3 increases the production of PI4P by recruiting PI4KB to the trans - Golgi network. - Inhibiting the production of PI4P (such as using a PI4KB inhibitor or overexpressing Sac1) will reduce STING activation. - Increasing the level of PI4P (such as using the OSBP inhibitor itraconazole or OSW - 1) can enhance STING activation. 3. **Study of STING mutants**: - The STING mutant (STING 4POSE) that is unable to bind PI4P cannot form clusters or be phosphorylated upon activation. - The STING mutant with the V154M mutation can form clusters and be phosphorylated in the Golgi apparatus without stimulation, but the effect of this mutation in the 4POSE background is inhibited. 4. **Targeting the PI4P - rich environment to promote STING activation**: - By targeting STING to a PI4P - rich environment (such as using the FAPP1 - PH domain), STING can be activated even in the absence of a STING agonist. ### Conclusion This study reveals the crucial role of PI4P in the process of STING activation and indicates that STING - dependent immune responses can be therapeutically modulated by regulating PI4P levels. These findings provide potential targets for the development of new immunotherapies.